Objectives: To explore the endophytic actinobacteria from the root tissue of Bryophyllum pinnatum (Lam.) Oken and its assessment for antimicrobial and antibiofilm activity against human pathogens. Methods: Surface sterilized root tissues of B. pinnatum have been seeded in different isolation media, to obtain colonies of endophytic actinobacteria. A polyphasic approach has been used to identify the isolate. Cross streak and disc diffusion methods have been used to perform the antimicrobial activity. However, the crystal violet assay assessed the antibiofilm activity, and its visualization was done under the light and fluorescent microscope. Findings: By polyphasic approach, Actinobacteria strain BpR-2 GER has been confirmed to be the member of genus Streptomyces, further through 16S rRNA gene sequence analysis, the strain has been identified as Streptomyces rochei that has 100% sequence similarity with Streptomyces rochei NRRL B-2410 (MUMD01000370). The isolate has exhibited extensive antagonistic interaction with Clinical and MTCC (Microbial Type Culture Collection) pathogens ranging from 9.75±0.71 to 19.38±1.30 mm. The highest zone of inhibition was recorded against Gram-positive bacteria B. subtilis (MTCC-441) of 19.38±1.30 mm and Gram-negative bacteria Proteus mirabilis (Clinical) of 16.25±0.71 mm. The strain has also exhibited significant antibiofilm potential against the MTCC-7443 (85.13±0.003 to 88.28±0.003%) and Clinical (85.13±0.003 to 88.28±0.003%) strain of Staphylococcus aureus. Novelty: This is the first report of S. rochei BpR-2 GER, a root endophyte of B. pinnatum with broad-spectrum antimicrobial activity and a significant antibiofilm property.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.